About: FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.02 (+2.72%)
FBLG NASDAQ FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock share price
FBLG price activity
Last Price
$1.020
Change (24hr)
0.03 USD (2.72%)
Volume
398.33K
Volume (4w avg)
-
Open
$0.97
Day Range
$0.97 - $1.24
Previous Close
$0.99
Last Trade
22 Oct, 8:21 pm GMT+0
Delayed
22 Oct, 8:21 pm GMT+0
FBLG price performance
Delayed
22 Oct, 8:21 pm GMT+0
FBLG Market Signals